KYBELLA® is the first and only FDA-approved injectable drug that contours and improves the appearance of submental fullness, sometimes referred to as a “double chin.”

It is a common, yet under-treated facial aesthetic condition that can:

  • Detract from an otherwise balanced and harmonious facial appearance
  • Lead to an older and heavier look
  • Impact a broad-range of adults, including both women and men
  • Be caused by aging, genetics, and/or weight gain

KYBELLA® is a non-human and non-animal formulation of deoxycholic acid, a naturally-occurring molecule in the body that aids in the breakdown and absorption of dietary fat. It is administered by subcutaneous injections directly into submental fat.

When injected into subcutaneous fat, KYBELLA® causes the destruction of fat cells. Once destroyed, those cells cannot store or accumulate fat. After the aesthetic response is achieved, retreatment is not expected.

What to Expect

In clinical studies, many patients experienced visible results in two to four treatment sessions spaced at least one month apart. Up to six treatments may be administered.  The number of treatment sessions necessary for desired results will vary from patient to patient.

Side Effects

The most common adverse reactions were edema/swelling, hematoma/bruising, pain, numbness, erythema, and induration. KYBELLA® is manufactured through a highly-controlled, FDA-regulated process and approved facility to ensure patient safety.

Before and After

Kybella before and after